| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 02/03/2010 | CN101641362A Substituted tetrahydroquinolines |
| 02/03/2010 | CN100586948C Crystalline anticholinergic, method for its preparation, and use thereof in medicament preparation |
| 02/02/2010 | US7655665 Nitromethylene derivatives and their use |
| 02/02/2010 | US7655640 silyl camptothecin derivatives for cancer and/or leukemia; cytotoxic; DNA-topoisomerase I inhibitors; antitumor agents; 7-trimethylsilyl-10-acetoxy camptothecin, 7-trimethylsilyl-11-fluoro camptothecin |
| 02/02/2010 | CA2485685C Calcium receptor modulating agents |
| 01/28/2010 | WO2010011748A2 Synthetic intermediates and processes |
| 01/28/2010 | US20100022579 Substituted tetrahydroquinolines |
| 01/28/2010 | US20100022550 Tetrahydrocarbazole derivatives useful as androgen receptor modulators |
| 01/28/2010 | US20100022527 Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral diseases |
| 01/28/2010 | US20100021387 Methods for Inducing Reversible Stasis |
| 01/28/2010 | US20100019169 Remote laser interrogation of threat clouds and surfaces |
| 01/28/2010 | CA2731228A1 Synthetic intermediates and processes |
| 01/27/2010 | EP2146997A1 Substituted furo[2,3-b]pyridine derivatives as cannabinoid-1 receptor modulators |
| 01/27/2010 | EP2146719A1 Process for making galantamine |
| 01/27/2010 | EP1461341B1 Process for preparing a heteroaromatic compound substituted with one or more ether groups |
| 01/26/2010 | US7652141 Immunosuppressants, analgesics, antiinflammatory agents |
| 01/26/2010 | US7652138 Anticholinergics, processes for preparing them and pharmaceutical composition containing them |
| 01/26/2010 | US7652058 Octahydropyrano[3,4-C]pyrrole tachykinin receptor antagonists |
| 01/26/2010 | US7652024 Obesity, diabetes, nicotine addiction, alcoholism, sexual dysfunction, including erectile dysfunction and female sexual dysfunction |
| 01/26/2010 | US7652014 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors |
| 01/26/2010 | US7652008 Tricyclic benzopyran compound as anti-arrhythmic agents |
| 01/26/2010 | US7652006 Substituted 1(2H)-phthalazinones and pharmaceutical compositions thereof |
| 01/26/2010 | CA2416016C Novel photochromic polymers and methods of synthesizing same |
| 01/26/2010 | CA2338854C Nitric esters and nitrate salts of specific drugs |
| 01/26/2010 | CA2275345C Pro-drugs and counterparts of camptothecin, their application as medicines |
| 01/21/2010 | WO2010009215A1 Nicotinic acid receptor agonist compounds useful to treat metabolic syndromes |
| 01/21/2010 | WO2010009212A1 Niacin derivatives useful to treat metabolic syndromes |
| 01/21/2010 | WO2010009195A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
| 01/21/2010 | WO2010007943A1 Nitrogenated heterocyclic compound |
| 01/21/2010 | WO2009046841A8 Piperidine and piperazine derivatives for treating tumours |
| 01/21/2010 | US20100016545 Process for the covalent coupling of two molecules by means of a diels-alder reaction with inverse electron requirement |
| 01/21/2010 | US20100016397 Pyrrole and Pyrazole DAAO Inhibitors |
| 01/21/2010 | US20100016341 Aspartyl protease inhibitors containing a tricyclic ring system |
| 01/21/2010 | US20100016323 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 01/21/2010 | US20100016277 Diazabicyclic central nervous system active agents |
| 01/21/2010 | US20100016154 Imaging system |
| 01/21/2010 | US20100015149 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 01/21/2010 | CA2730593A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
| 01/21/2010 | CA2728095A1 Pyrazole-containing tricyclic compounds as antagonists of an ep1 receptor |
| 01/20/2010 | CN101631792A Novel phosphodi esterase inhibitors |
| 01/20/2010 | CN101631791A Substituted spirochromanone derivatives as ACC inhibitors |
| 01/20/2010 | CN101628888A Inhibitors of cytosolic phospholipase A2 |
| 01/19/2010 | US7649015 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing |
| 01/19/2010 | US7649014 Inhibit uncoupling protein-2 (UCP2); treating deficient first-phase insulin secretion, non-insulin dependent diabetes mellitus, and ischemia |
| 01/19/2010 | US7649001 Fused benzene derivative and use |
| 01/19/2010 | US7648995 R(—)-11-hydroxyaporphine derivatives and uses thereof |
| 01/19/2010 | US7648994 Steroidal alkaloids that can be used in the treatment of hedgehog pathway related disorders, particularly cancer and psoriasis |
| 01/19/2010 | US7648986 Hypertension, atherosclerosis, restenosis, cerebral ischemia, cerebral vasospasm, or erectile dysfunction; 2-(5-chloro-2-thienyl)-N-(1H-indazol-5-yl)thieno[3,2-d]pyrimidin-4-amine |
| 01/19/2010 | US7648975 Macrocyclic quinazoline derivatives as antiproliferative agents |
| 01/19/2010 | CA2239904C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/14/2010 | WO2010003313A1 Icotinib hydrochloride, synthesis, crystallographic form, medical combination, and uses thereof |
| 01/14/2010 | US20100010032 Camptothecin derivatives with antitumor activity |
| 01/14/2010 | US20100010016 Bicyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 01/14/2010 | US20100010009 Furo[3,2-B] pyrrol -3-one derivatives and their use as cysteinyl porteinase inhibitors |
| 01/14/2010 | US20100009935 Resistance-repellent retroviral protease inhibitors |
| 01/14/2010 | US20100009353 Dye Compounds and the Use of their Labelled Conjugates |
| 01/14/2010 | CA2730319A1 Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 01/14/2010 | CA2730314A1 Bicyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 01/14/2010 | CA2730311A1 Icotinib hydrochloride, synthesis, crystalline forms, drug combinations, and uses thereof |
| 01/13/2010 | EP2143444A1 Compositions for inhibition of anglogenesis |
| 01/13/2010 | EP2142538A1 Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists |
| 01/13/2010 | CN100579980C Ru(II) complex with anticancer liveness and method for preparing the same |
| 01/13/2010 | CN100579976C P38 inhibitors and methods of use thereof |
| 01/13/2010 | CN100579518C Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 01/12/2010 | US7645882 Renal protective agents which inhibit vitamin B6 deficiency disease as side effect; inhibiting advanced glycosylation endproducts |
| 01/12/2010 | US7645761 Indoline derivatives |
| 01/12/2010 | US7645758 (4-Methyl-piperazin-1-yl)-(6H-thieno[2,3-b]pyrrol-5-yl)-methanone; (2,3-Dichloro-6H-thieno[2,3-b]pyrrol-5-yl)-(4-methyl-piperazin-1-yl)-methanone; histamine H4 receptor antagonist; treats allergic rhinitis |
| 01/12/2010 | US7645753 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives |
| 01/12/2010 | CA2407838C Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/12/2010 | CA2403835C Anti-viral pyrimidine nucleoside analogues |
| 01/12/2010 | CA2391643C Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors |
| 01/07/2010 | WO2010002933A1 Oxindole compounds |
| 01/07/2010 | WO2010002483A1 Optionally condensed dihydro pyridine, dihydropyrimidine and dihydro pyrane derivatives acting as late sodium channel blockers |
| 01/07/2010 | WO2010002010A1 Novel spirochromanone carboxylic acids |
| 01/07/2010 | WO2010001990A1 Tetracyclic compound |
| 01/07/2010 | WO2010000773A1 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides |
| 01/07/2010 | US20100004241 Non-imidazole aryloxyalkylamines |
| 01/07/2010 | US20100004230 Azatricyclic compounds and their use |
| 01/07/2010 | CA2729724A1 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides |
| 01/07/2010 | CA2729412A1 Novel spirochromanone carboxylic acids |
| 01/07/2010 | CA2728559A1 Cdk modulators |
| 01/06/2010 | EP2141168A1 Heteroaryl derivatives |
| 01/06/2010 | EP2139899A1 Crystalline forms of topotecan hydrochloride and processes for making the same |
| 01/06/2010 | CN101619066A Isoquinoline compound or salt thereof, medicinal composition, preparation method and application thereof |
| 01/06/2010 | CN101619065A Isoquinoline compound or salt thereof, medicinal composition, preparation method and application thereof |
| 01/06/2010 | CN100577665C Antineoplastic active canthardin derivative and method for preparing same |
| 01/06/2010 | CN100577664C Spirocyclic cyclohexane derivatives |
| 01/06/2010 | CN100577651C Lactam compound and medicinal use thereof |
| 01/05/2010 | US7642359 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 01/05/2010 | US7642268 Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament |
| 01/05/2010 | US7642267 Benzimidazole and pyridylimidazole derivatives |
| 01/05/2010 | US7642265 Benzimidazoles and analogs thereof as antivirals |
| 01/05/2010 | US7642252 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof |
| 01/05/2010 | CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 01/05/2010 | CA2358923C Water-soluble rhodamine dyes and conjugates thereof |
| 12/31/2009 | US20090326225 Novel Process for the Preparation of Hexacyclic Compounds |
| 12/31/2009 | US20090326219 Process for manufacturing extremely pure benzazepine derivatives |
| 12/31/2009 | US20090326218 Azepinoindole and Pyridoindole Derivatives as Pharmaceutical Agents |
| 12/31/2009 | US20090326015 Compounds with embedded benzopyran motif for core structures and preparation method thereof |
| 12/31/2009 | US20090325996 Camptothecin derivatives and their use |